2011
Global Bioenergies and LanzaTech launch a collaboration to assess the bioproduction of isobutene from carbone monoxide
Global Bioenergies and LanzaTech Ltd, two industrial biology companies, today announce the beginning of a feasibility study to examine whether Global Bioenergies’ pathway, leading to the direct production of isobutene, can be functionally transferred into LanzaTech’s carbon monoxide using organism.
Agenda
- 29 - 30 November 2012
- World orphan Drug Congress
- Geneva, Switzerland
- 21-22 May 2012
- The 5th Annual European Life Science CEO Forum
- Palm Beach County Convention Center, Florida
- May 23, 24 & 25, 2012
- 14th Annual PHARMACEUTICAL CONFERENCE
- Milano (Lake Maggiore), ITALY
- 21 - 23 May 2012
- World Stem Cells & Regenerative Medicine Congress
- Victoria Park Plaza, London, UK
In order to receive
Genopole® press releases®,
please provide your coordinates
to Press Service


